Inhibition of mammalian-target-of-rapamycin-complex-1 (mTORC1) due to merlin activation leads to the inhibition of mRNA translation, which causes an increase in apoptosis limiting cell survival and blocking tumor initiation[32]. Here, NF2 is linked to neoplasm.